Lutikizumab

Tax included
Lutikizumab (ABT-981) is an anti-IL-1α and IL-1β dual variable domain immunoglobulin. Lutikizumab binds and inhibits IL-1α and IL-1β. Lutikizumab can be used for the research of osteoarthritis.
MedChemExpress 
HY-P99721

Data sheet

Size
Multiple sizes
Reactivity
Interleukin Related
CAS
1791411-57-8